(Q41814837)

12 October 2017

Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells (English)

1 reference

12 October 2017

0 references

1 reference

3

Peter Heiduschka

1 reference

12 October 2017

Swaantje Peters

1

1 reference

12 October 2017

Sylvie Julien

2

1 reference

12 October 2017

Salvatore Grisanti

4

1 reference

12 October 2017

Focke Ziemssen

5

1 reference

12 October 2017

Martin Adler

6

1 reference

12 October 2017

Ulrich Schraermeyer

7

1 reference

12 October 2017

Karl-Ulrich Bartz-Schmidt

8

1 reference

12 October 2017

language of work or name

English

0 references

publication date

19 December 2006

1 reference

British Journal of Ophthalmology

12 October 2017

1 reference

12 October 2017

91

1 reference

12 October 2017

6

1 reference

12 October 2017

827-831

1 reference

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Ranibizumab for neovascular age-related macular degeneration

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

The role of bevacizumab as first-line therapy for colon cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Role of growth factors and the wound healing response in age-related macular degeneration

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

VEGF and the quest for tumour angiogenesis factors

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Rapid isolation of choriocapillary endothelial cells by Lycopersicon esculentum-coated Dynabeads

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Plasmalemmal proteins of cultured vascular endothelial cells exhibit apical-basal polarity: analysis by surface-selective iodination

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Pegaptanib for neovascular age-related macular degeneration

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Vessel formation by choroidal endothelial cells in vitro is modulated by retinal pigment epithelial cells

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955593

Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17179166

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intravitreal bevacizumab for choroidal neovascularization and cystoid macular edema: a cost-effective treatment?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17179166

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17179166

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BJO.2006.109702

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

17179166

1 reference